In vivo molecular imaging using nanomaterials: General in vivo characteristics of nano-sized reagents and applications for cancer diagnosis(Review)

Molecular Membrane Biology

Volumn 27, Issue 7, 2010, Pages 274-285

  Rosenblum, Lauren T ^a   Kosaka, Nobuyuki ^a   Mitsunaga, Makoto ^a   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

dendrimer; iron oxide particle; Molecular imaging; nanomaterial; quantum dot

Indexed keywords

DENDRIMER; ERBIUM; FLUORIDE; GADOLINIUM; NANOMATERIAL; POLYAMIDOAMINE; QUANTUM DOT; RADIOLIGAND; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; UPCONVERSION PHOSPHORS; YTTERBIUM;

AUTOFLUORESCENCE; CANCER DIAGNOSIS; CELLULAR DISTRIBUTION; ENERGY; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HUMAN; IN VIVO STUDY; KIDNEY; LIVER; LYMPHANGIOGRAPHY; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE; SIGNAL TRANSDUCTION;

ANIMALS; CELL TRACKING; CONTRAST MEDIA; DENDRIMERS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; NEOPLASMS; QUANTUM DOTS;

EID: 78049327489     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.3109/09687688.2010.481640     Document Type: Review

References (62)

1. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. 2009. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompa-tibility and therapeutic efficacy. Adv Drug Deliv Rev 61: 428-437.
2. Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E. 2002.Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99:12617-12621.
3. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. 2004. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104:1217-1223.
4. Ballou B, Ernst LA, Andreko S, Harper T, Fitzpatrick JAJ, Waggoner AS, Bruchez MP. 2007. Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconj Chem 18:389-396.
5. Barrett T, Ravizzini G, Choyke PL, Kobayashi H. 2009. Dendri-mers in medical nanotechnology application of dendrimer molecules in bioimaging and cancer treatment. IEEE Eng Med Biol Mag 28:12-22.
6. Bulte JWM, Kraitchman DL. 2004. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484-499.
7. Cai WB, Hsu AR, Li ZB, Chen XY. 2007. Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Res Lett 2:265-281.
8. Chatteriee DK, Rufalhah AJ, Zhang Y. 2008a. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 29:937-943.
9. Chatterjee DK, Fong LS, Zhang Y. 2008b. Nanoparticles in photodynamic therapy: An emerging paradigm. Adv Drug Deliv Rev 60:1627-1637.
10. Choi HS, Liu W, Liu F, Nasr K, Misra P, Bawendi MG, Frangioni JV. 2010. Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol 5:42-47.
11. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ipe BI, Bawendi MG, Frangioni JV. 2007. Renal clearance of quantum dots. Nature Biotechnol 25:1165-1170.
12. Corot C, Robert P, Idee JM, Port M. 2006. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 58:1471-1504.
13. Delehanty JB, Boeneman K, Bradburne CE, Robertson K, Medintz IL. 2009. Quantum dots: A powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery. Expert Opin Drug Deliv 6:1091-112.
14. Duncan R, Izzo L. 2005. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57:2215-2237.
15. Efros AL. 1982. Interband absorption of light in a semiconductor sphere. Sov Phys Semiconductors-USSR 16:772-775.
16. Frangioni JV, Hajjar RJ. 2004. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 110: 3378-3383.
17. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, Van De Kaa CH, De la Rosette J, Weissleder R. 2003.Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491-2499. (Pubitemid 36706536)
18. Hayashi K, Jiang P, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Moossa AR, Bouvet M, Hoffman RM. 2007. Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res 67:8223-8228.
19. Hezinger AFE, Tessmar J, Gopferich A. 2008. Polymer coating of quantum dots-a powerful tool toward diagnostics and senso-rics. Eur J Pharmaceut Biopharmaceut 68:138-152.
20. Jain R, Dandekar P, Patravale V. 2009. Diagnostic nanocarriers for sentinel lymph node imaging. J Controlled Release 138:90-102.
21. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. 2003. Long-term multiple color imaging of live cells using quantum dot biocon-jugates. Nature Biotechnol 21:47-51.
22. Jalil RA, Zhang Y. 2008. Biocompatibility of silica coated NaYF4 upconversion fluorescent nanocrystals. Biomaterials 29: 4122-4128.
23. Jamieson T, Bakhshi R, Petrova D, Pocock R, Imani M, Seifalian AM. 2007. Biological applications of quantum dots. Biomaterials 28:4717-4732.
24. Kaminskas LM, Boyd BJ, Karellas P, Krippner GY, Lessene R, Kelly B, Porter CJH. 2008. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGy-lated poly L-lysine dendrimers. Molec Pharmaceut 5:449-463.
25. Kim S, Fisher B, Eisler HJ, Bawendi M. 2003. Type-II quantum dots: CdTe/CdSe(core/shell) and CdSe/ZinTe(core/shell) het-erostructures. J Am Chem Soc 125:11466-11467.
26. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG, Frangioni JV. 2004. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nature Biotechnol 22:93-97.
27. Kobayashi H, Brechbiel MW. 2003. Dendrimer-based macromo-lecular MRI contrast agents: Characteristics and application. Molec Imag 2:1-10.
28. Kobayashi H, Brechbiel MW. 2004. Dendrimer-based nanosized MRI contrast agents. Curr Pharmaceut Biotechnol 5:539-549.
29. Kobayashi H, Brechbiel MW. 2005. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 57: 2271-2286.
30. Kobayashi H, Hama Y, Koyama Y, Barrett T, Regino CAS, Urano Y, Choyke PL. 2007a. Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett 7:1711-1716.
31. Kobayashi H, Jo SK, Kawamoto S, Yasuda H, Hu XZ, Knopp MV, Brechbiel MW, Choyke PL, Star RA. 2004a. Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure. J Magnet Res Imag 20:512-518.
32. Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL. 2006. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: Comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Controlled Release 111:343-351.
33. Kobayashi H, Kawamoto S, Brechbiel MW, Bernardo M, Sato N, Waldmann TA, Tagaya Y, Choyke PL. 2005. Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle. Neoplasia 7:984-991.
34. Kobayashi H, Kawamoto S, Jo SK, Bryant HL, Brechbiel MW, Star RA. 2003a. Macromolecular MRI contrast agents with small dendrimers: Pharmacokinetic differences between sizes and cores. Bioconj Chem 14:388-394.
35. Kobayashi H, Kawamoto S, Saga T, Sato N, Hiraga A, Ishimori T, Konishi J, Togashi K, Brechbiel MW. 2001a. Positive effects of polyethylene glycol conjugation to generation-4 polyamidoa-mine dendrimers as macromolecular MR contrast agents. Magnet Reson Med 46:781-788.
36. Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, Waldmann TA. 2004b. Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Nat Cancer Inst 96:703-708.
37. Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW. 2003b. Micro-magnetic resonance lymphangi-ography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res 63:271-276.
38. Kobayashi H, Kosaka N, Ogawa M, Morgan NY, Smith PD, Murray CB, Ye XC, Collins J, Kumar GA, Bell H, Choyke PL. 2009. In vivo multiple color lymphatic imaging using upconverting nanocrystals. J Materials Chem 19: 6481-6484.
39. Kobayashi H, Koyama Y, Barrett T, Hama Y, Regino CAS, Shin IS, Jang BS, Le N, Paik CH, Choyke PL, Urano Y. 2007b. Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. Acs Nano 1:258-264.
40. Kobayashi H, Saga T, Kawamoto S, Sato N, Hiraga A, Ishimori T, Konishi J, Togashi K, Brechbiel MW. 2001b. Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64). Cancer Res61:4966-4970.
41. Kojima C, Kono K, Maruyama K, Takagishi T. 2000. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconj Chem 11:910-917.
42. Kosaka N, Ogawa M, Sato N, Choyke PL, Kobayashi H. 2009. In vivo real-time, multicolor, quantum dot lymphatic imaging. J Invest Dermatol 129:2818-2822.
43. Lim J, Guo Y, Rostollan CL, Stanfield J, Hsieh JT, Sun XK, Simanek EE. 2008. The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers. Molec Pharmaceut 5:540-547.
44. Lin SP, Brown JJ. 2007. MR contrast agents: Physical and phar-macologic basics. J Magnet Reson Imag 25:884-899.
45. Margolis DJA, Hoffman JM, Herfkens RJ, Jeffrey RB, Quon A, Gambhir SS. 2007. Molecular imaging techniques in body imaging. Radiology 245:333-356.
46. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. 2005. Quantum dot bioconjugates for imaging, labelling and sensing. Nature Materials 4:435-446.
47. MooreA, Sun PZ, Cory D,HogemannD,WeisslederR,Lipes MA. 2002. MRI of insulitis in autoimmune diabetes. Magn Reson Med 47:751-758.
48. Pelley JL, Daar AS, Saner MA. 2009. State of academic knowledge on toxicity and biological fate of quantum dots. Toxicolog Sci 112:276-296.
49. Rogers WJ, Meyer CH, Kramer CM. 2006. Technology insight: In vivo cell tracking by use of MRI. Nature Clin Pract Cardiovasc Med 3:554-562.
50. Rzigalinski BA, Strobl JS. 2009. Cadmium-containing nanoparti-cles: Perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharmacol 238:280-288.
51. Shapiro EM, Skrtic S, Sharer K,Hill JM, Dunbar CE, Koretsky AP. 2004. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 101:10901-10906.
52. Smith AM, Dave S, Nie SM, True L, Gao XH. 2006. Multicolor quantum dots for molecular diagnostics of cancer. Exp Rev Molec Diagnost 6:231-244.
53. Smith AM, Duan HW, Mohs AM, Nie SM. 2008. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev 60:1226-1240.
54. So MK, Xu CJ, Loening AM, Gambhir SS, Rao JH. 2006. Self-illuminating quantum dot conjugates for in vivo imaging. Nature Biotechnol 24:339-343.
55. Tanimoto A, Yuasa Y, Shinmoto H, Jinzaki M, Imai Y, Okuda S, Kuribayashi S. 2002. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: Pulse sequence effects and Kupffer cell function. Radiology 222:661-666.
56. Thorek DLJ, Chen A, Czupryna J, Tsourkas A. 2006. Superpar-amagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Engine 34:23-38.
57. Voura EB, Jaiswal JK, Mattoussi H, Simon SM. 2004. Tracking metastatic tumor cell extravasation with quantum dot nanocrys-tals and fluorescence emission-scanning microscopy. Nature Med 10:993-998.
58. Wang F, Liu XG. 2008. Upconversion multicolor fine-tuning: Visible to near-infrared emission from lanthanide-doped NaYF4 nanoparticles. J Am Chem Soc 130:5642-5643.
59. Yao HQ, Zhang Y, Xiao F, Xia ZY, Rao JH. 2007. Quantum dot/ bioluminescence resonance energy transfer based highly sensitive detection ofproteases. Angewandte Chem-Int Ed46:4346-4349.
60. Yi GS, Lu HC, Zhao SY, Yue G, Yang WJ, Chen DP, Guo LH. 2004. Synthesis, characterization, and biological application of size-controlled nanocrystalline NaYF4: Yb,Er infrared-to-visible up-conversion phosphors. Nano Lett 4:2191-2196.
61. Young IR, Clarke GJ, Bailes DR, Pennock JM, Doyle FH, Bydder GM. 1981. Enhancement of relaxation rate with paramagnetic contrast agents in NMR imaging. J Comput Tomogr 5:543-547.
62. Zijlmans H, Bonnet J, Burton J, Kardos K, Vail T, Niedbala RS, Tanke HJ. 1999. Detection of cell and tissue surface antigens using up-converting phosphors: A new reporter technology. Analyt Biochem 267:30-36.